ARCHIVES

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | December 29, 2006

Download PDF Visit The Full Archive

Related Articles

ORI finds Hopkins Coordinator Falsified Information On Grant

May 16, 1997

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

January 25, 2002

Senate, House Budget Plans Likely To Result In Modest Funding Increases For NIH, NCI

May 11, 1990

Army Will Outspend NCI In Breast Cancer In FY93, But How To Apply For a Grant?

October 16, 1992

Protocols Approved By NCI During January 2004

February 27, 2004

Bladder Cancer Survival Rate Rises With Neoadjuvant Chemo

September 26, 2003